CME Group price target lowered to $324 from $353 at Morgan Stanley
Morgan Stanley lowered the firm's price target on CME Group to $324 from $353 and keeps an Overweight rating on the shares. Brokers & Exchanges are expected to deliver slightly better-than-consensus Q2 earnings driven by stronger volumes and volatility, with brokers favored for attractive valuations, growth potential, and multiple upcoming catalysts, the analyst tells investors in a research note.
Morgan Stanley lowered the firm's price target on CME Group to $324 from $353 and keeps an Overweight rating on the shares.
Brokers & Exchanges are expected to deliver slightly better-than-consensus Q2 earnings driven by stronger volumes and volatility, with brokers favored for attractive valuations, growth potential, and multiple upcoming catalysts, the analyst tells investors in a research note.